SHANGHAI and BOSTON, Sept. 15, 2025 /PRNewswire/ -- Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics company, today announced that the ...
Novartis (NYSE:NVS) (OTCPK:NVSEF) has expanded its collaboration with Argo Biopharma, with multi-asset license and option agreements worth up to $5.2B with the Chinese biotech for several ...
Sept 3 (Reuters) - Swiss drugmaker Novartis (NOVN.S), opens new tab has signed an up to $5.2 billion licensing and options deal with Argo Biopharmaceutical for its experimental candidates that target ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback